Zobrazeno 1 - 10
of 40
pro vyhledávání: ''
Publikováno v:
Journal of Healthcare Engineering, Vol 2021 (2021)
Journal of Healthcare Engineering
Journal of Healthcare Engineering
Gastric cancer is a malignant tumor that originates from the epithelium of the gastric mucosa. It is the result of a combination of multiple factors, but the current research has not yet clarified its pathogenesis, so further research and exploration
Autor:
Salvatore Nardello, Philip Albaneze, Mengying Deng, John M. Daly, Elin R. Sigurdson, Nicole E Sharp, Nicole M. Melchior, Darren B. Sachs, Allison A. Aggon, Richard J. Bleicher
Publikováno v:
Breast J
BACKGROUND: Prospective trials demonstrate that sentinel node (SN) biopsy after neoadjuvant chemotherapy (NACT) has a significant false negative rate (FNR) when only 1 or 2 SNs are removed. It is unknown whether this increased FNR correlates with an
Autor:
Gulisa Turashvili, Hannah Y Wen
Publikováno v:
The Breast Journal. 26:1199-1207
Most invasive breast cancers express hormone receptors (HR) and typically have a favorable prognosis following endocrine therapy. Patients at a higher risk of recurrence can be identified by multigene prognostic classifiers such as the 21-gene recurr
Publikováno v:
The Breast Journal. 26:1221-1226
Ductal carcinoma in situ (DCIS) is a nonobligate precursor of invasive breast cancer. Current clinical trials are exploring active surveillance (AS) of DCIS. The purpose of this study is to characterize current practice trends in the use of AS. The f
Publikováno v:
The Breast Journal. 26:952-959
Adjuvant hormonal therapy (HT) is important for the management of hormone-sensitive breast cancer. However, the timeliness for adjuvant HT and the consequences of delayed initiation of treatment have not been analyzed. The purpose of this study was t
Publikováno v:
The Breast Journal. 26:112-119
Fulvestrant monotherapy is approved for postmenopausal women with hormone receptor-positive, metastatic breast cancer (MBC) who progressed following antiendocrine therapy, or those with hormone receptor-positive, human epidermal receptor 2-negative a
Publikováno v:
The Breast Journal. 25:418-424
Background: Metaplastic breast carcinomas (MpBCs) are rare, aggressive breast cancers. Due to the scant literature of this disease most guidelines do not give recommendation for this entity. The aim of the study was to review the clinicopathologic fe
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 40:299-303
Summary What is known and objective The Food and Drug Administration (FDA) instituted a risk evaluation mitigation strategy (REMS) for erythropoiesis-stimulating agent (ESA) use in patients with cancer in February 2010. Implementation of REMS was con
Publikováno v:
Journal of Computational Medicine. 2014:1-5
Numerous mathematical and computational models have arisen to study and predict the effects of diverse therapies against cancer (e.g., chemotherapy, immunotherapy, and even therapies under research with oncolytic viruses) but, unfortunately, few effo
Autor:
M. Esfandbod, Yoke Mun Chan, Mirnalini Kandiah, M. Zarif Yeganeh, Masoud Vakili, Mohsen Hosseinzadeh, Zarintaj Malihi
Publikováno v:
European Journal of Cancer Care. 24:542-552
This study aimed to evaluate how changes in dietary intake among acute lymphoblastic and acute myeloid leukaemia (ALL and AML) patients affect nutritional status after the first induction chemotherapy. Dietary intake was assessed using 24-h recall an